These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 33598567

  • 1. Does the effectiveness of IUI in couples with unexplained subfertility depend on their prognosis of natural conception? A replication of the H2Oil study.
    van Eekelen R, Rosielle K, van Welie N, Dreyer K, van Wely M, Mol BW, Eijkemans MJ, Mijatovic V, van Geloven N.
    Hum Reprod Open; 2020; 2020(4):hoaa047. PubMed ID: 33598567
    [Abstract] [Full Text] [Related]

  • 2. Is IUI with ovarian stimulation effective in couples with unexplained subfertility?
    van Eekelen R, van Geloven N, van Wely M, McLernon DJ, Mol F, Custers IM, Steures P, Bhattacharya S, Mol BW, van der Veen F, Eijkemans MJ.
    Hum Reprod; 2019 Jan 01; 34(1):84-91. PubMed ID: 30395266
    [Abstract] [Full Text] [Related]

  • 3. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
    Wessel JA, Mochtar MH, Besselink DE, Betjes H, de Bruin JP, Cantineau AEP, Groenewoud ER, Hooker AB, Lambalk CB, Kwee J, Kaaijk EM, Louwé LA, Maas JWM, Mol BWJ, van Rumste MME, Traas MAF, Goddijn M, van Wely M, Mol F.
    Hum Reprod; 2022 Nov 24; 37(12):2808-2816. PubMed ID: 36331493
    [Abstract] [Full Text] [Related]

  • 4. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
    Wessel JA, Mol F, Danhof NA, Bensdorp AJ, Tjon-Kon Fat RI, Broekmans FJM, Hoek A, Mol BWJ, Mochtar MH, van Wely M, INeS and SUPER Study Group.
    Hum Reprod; 2021 Feb 18; 36(3):817-825. PubMed ID: 33347597
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
    van Eekelen R, Eijkemans MJ, Mochtar M, Mol F, Mol BW, Groen H, van Wely M.
    Hum Reprod; 2020 Sep 02; 35(9):2037-2046,. PubMed ID: 32876323
    [Abstract] [Full Text] [Related]

  • 6. Natural conception rates in couples with unexplained or mild male subfertility scheduled for fertility treatment: a secondary analysis of a randomized controlled trial.
    van Eekelen R, Tjon-Kon-Fat RI, Bossuyt PMM, van Geloven N, Eijkemans MJC, Bensdorp AJ, van der Veen F, Mol BW, van Wely M.
    Hum Reprod; 2018 May 01; 33(5):919-923. PubMed ID: 29538638
    [Abstract] [Full Text] [Related]

  • 7. Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.
    van Welie N, Dreyer K, van Rijswijk J, Verhoeve HR, Goddijn M, Nap AW, Smeenk JMJ, Traas MAF, Rijnsaardt-Lukassen HGM, van Dongen AJCM, Bourdrez P, de Bruin JP, Sluijmer AV, Gijsen AP, van de Ven PM, Lambalk CB, Mijatovic V, Mol BWJ.
    Hum Reprod; 2019 Dec 01; 34(12):2391-2398. PubMed ID: 31887222
    [Abstract] [Full Text] [Related]

  • 8. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility.
    McLernon DJ, Lee AJ, Maheshwari A, van Eekelen R, van Geloven N, Putter H, Eijkemans MJ, van der Steeg JW, van der Veen F, Steyerberg EW, Mol BW, Bhattacharya S.
    Hum Reprod; 2019 Jun 04; 34(6):1126-1138. PubMed ID: 31119290
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neurodevelopmental outcomes of school-age children conceived after hysterosalpingography with oil-based or water-based iodinated contrast: long-term follow-up of a nationwide randomized controlled trial.
    Keestra SM, Van Welie N, Dreyer K, Van Eekelen R, Roseboom TJ, Oosterlaan J, Mol BW, Finken MJJ, Mijatovic V, Königs M.
    Hum Reprod; 2024 Oct 01; 39(10):2287-2296. PubMed ID: 39198011
    [Abstract] [Full Text] [Related]

  • 11. Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?
    van Rijswijk J, van Welie N, Dreyer K, Tajik P, Lambalk CB, Hompes P, Mijatovic V, Mol BWJ, Zafarmand MH.
    Hum Reprod Open; 2019 Oct 01; 2019(3):hoz015. PubMed ID: 31334364
    [Abstract] [Full Text] [Related]

  • 12. Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
    Kamphuis D, van Eekelen R, van Welie N, Dreyer K, van Rijswijk J, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, van Baal WM, Traas MAF, van Peperstraten AM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, Lambeek AF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Tros R, Lambalk CB, Stoker J, van Wely M, Bossuyt PMM, Mol BWJ, Mijatovic V.
    Hum Reprod; 2024 Jun 03; 39(6):1222-1230. PubMed ID: 38600625
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis.
    Danhof NA, van Eekelen R, Repping S, Mol BWJ, van der Veen F, van Wely M, Mochtar MH, SUPER Study group .
    Hum Reprod Open; 2020 Jun 03; 2020(1):hoz024. PubMed ID: 31934648
    [Abstract] [Full Text] [Related]

  • 16. Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial.
    van Welie N, van Rijswijk J, Dreyer K, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, van Baal WM, Traas MAF, van Peperstraten AM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, Lambeek AF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Tros R, Lambalk CB, Stoker J, van Wely M, Bossuyt PMM, Mol BWJ, Mijatovic V.
    Hum Reprod; 2022 May 03; 37(5):969-979. PubMed ID: 35220432
    [Abstract] [Full Text] [Related]

  • 17. The web-based Pleasure&Pregnancy programme in the treatment of unexplained infertility: a randomized controlled trial.
    Dreischor F, Dancet EAF, Lambalk CB, van Lunsen HW, Besselink D, van Disseldorp J, Boxmeer J, Brinkhuis EA, Cohlen BJ, Hoek A, de Hundt M, Janssen CAH, Lambers M, Maas J, Nap A, Perquin D, Verberg M, Verhoeve HR, Visser J, van der Voet L, Mochtar MH, Goddijn M, Laan E, van Wely M, Custers IM.
    Hum Reprod; 2024 Oct 01. PubMed ID: 39352942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers.
    Tjon-Kon-Fat RI, Tajik P, Zafarmand MH, Bensdorp AJ, Bossuyt PMM, Oosterhuis GJE, van Golde R, Repping S, Lambers MDA, Slappendel E, Perquin D, Pelinck MJ, Gianotten J, Maas JWM, Eijkemans MJC, van der Veen F, Mol BW, van Wely M, INeS study group†.
    Hum Reprod; 2017 May 01; 32(5):1028-1032. PubMed ID: 28333222
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.